Shares of Beximco Pharmaceuticals Limited (LON:BXP – Get Free Report) fell 2.6% on Monday . The company traded as low as GBX 36 ($0.46) and last traded at GBX 37.50 ($0.48). 62,626 shares were traded during trading, an increase of 17% from the average session volume of 53,388 shares. The stock had previously closed at GBX 38.50 ($0.49).
Beximco Pharmaceuticals Trading Down 2.6 %
The company has a debt-to-equity ratio of 14.73, a current ratio of 1.80 and a quick ratio of 0.37. The business’s fifty day moving average price is GBX 38.88 and its 200 day moving average price is GBX 38.56. The company has a market cap of £167.29 million, a price-to-earnings ratio of 468.75 and a beta of 0.63.
About Beximco Pharmaceuticals
Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.
See Also
- Five stocks we like better than Beximco Pharmaceuticals
- Stock Sentiment Analysis: How it Works
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- Are Penny Stocks a Good Fit for Your Portfolio?
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- What Does Downgrade Mean in Investing?
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for Beximco Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beximco Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
